Phospholipase D-mTOR signaling is compromised in a rat model of depression

Journal of Psychiatric Research

Volumn 47, Issue 5, 2013, Pages 579-585

  Feng, Pingfu ^a,b   Huang, Chunfa ^a,b,c  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Choline; Depression; MTOR; P70S6 kinase; Phosphatidic acid; Phospholipase D

Indexed keywords

CHOLINE; CLOMIPRAMINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; S6 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION;

EID: 84875249682     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.01.006     Document Type: Article

References (46)

1. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., et al. NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses. Nature 2011, 475:91-95.
2. Cai D., Zhong M., Wang R., Netzer W.J., Shields D., Zheng H., et al. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1936-1940.
3. Caraci F., Copani A., Nicoletti F., Drago F. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. European Journal of Pharmacology 2010, 626:64-71.
4. Cazzolli R., Shemon A.N., Fang M.Q., Hughes W.E. Phospholipid signalling through phospholipase D and phosphatidic acid. IUBMB Life 2006, 58:457-461.
5. Chopra K., Kumar B., Kuhad A. Pathobiological targets of depression. Expert Opinion Therapeutic Targets 2011, 15:379-400.
6. Dazert E., Hall M.N. mTOR signaling in disease. Current Opinion in Cell Biology 2011, 23:744-755.
7. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biological Psychiatry 2006, 59:1136-1143.
8. Duman R.S., Malberg J., Thome J. Neural plasticity to stress and antidepressant treatment. Biological Psychiatry 1999, 46:1181-1191.
9. Ende G., Braus D.F., Walter S., Weber-Fahr W., Henn F.A. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Archives of General Psychiatry 2000, 57:937-943.
10. Fang Y., Vilella-Bach M., Bachmann R., Flanigan A., Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001, 294:1942-1945.
11. Feng P., Guan Z., Yang X., Fang J. Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Research 2003, 991:195-205.
12. Feng P., Vurbic D., Wu Z., Hu Y., Strohl K.P. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. Journal of Psychopharmacology 2008, 22:784-791.
13. Foster D.A. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochimica et Biophysica Acta 2009, 1791:949-955.
14. Frondorf K., Henkels K.M., Frohman M.A., Gomez-Cambronero J. Phosphatidic acid is a leukocyte chemoattractant that acts through S6 kinase signaling. The Journal of Biological Chemistry 2010, 285:15837-15847.
15. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011, 36:2589-2602.
16. Hong S.T., Choi C.B., Park C., Moon H.Y., Hong K.S., Cheong C., et al. Specific hippocampal choline decrease in an animal model of depression. British Journal of Radiology 2009, 82:549-553.
17. Hong S.T., Choi C.B., Park C.S., Hong K.S., Cheong C.J., Jeon Y.W., et al. Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy. Journal of Neuroscience Methods 2007, 165:89-94.
18. Huang C., Bruggeman L.A., Hydo L.M., Miller R.T. Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes. Experimental Cell Research 2012, 318:1075-1085.
19. Huang C., Wykle R.L., Daniel L.W., Cabot M.C. Identification of phosphatidylcholine-selective and phosphatidylinositol-selective phospholipases D in Madin-Darby canine kidney cells. The Journal of Biological Chemistry 1992, 267:16859-16865.
20. Huang Y., Chen W., Li Y., Wu X., Shi X., Geng D. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy. Psychiatry Research 2010, 182:48-52.
21. Isaksson A., Walther L., Hansson T., Andersson A., Alling C. Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Testing and Analysis 2011, 3:195-200.
22. Jernigan C.S., Goswami D.B., Austin M.C., Iyo A.H., Chandran A., Stockmeier C.A., et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Progress Neuro-psychopharmacology and Biological Psychiatry 2011, 35:1774-1779.
23. Jin J.K., Kim N.H., Lee Y.J., Kim Y.S., Choi E.K., Kozlowski P.B., et al. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients. Neuroscience Letters 2006, 407:263-267.
24. Jung K., Min D.S., Sim K.B., Ahn M., Kim H., Cheong J., et al. Upregulation of phospholipase D1 in the spinal cords of rats with clip compression injury. Neuroscience Letters 2003, 336:126-130.
25. Kanfer J.N., Singh I.N., Pettegrew J.W., McCartney D.G., Sorrentino G. Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell. Journal of Lipid Mediators and Cell Signalling 1996, 14:361-363.
26. Kim M.D., Min D.S., Sim K.B., Cho H.J., Shin T. Expression and potential role of phospholipase D1 in cryoinjured cerebral cortex of rats. Histology and Histopathology 2004, 19:1015-1019.
27. Klein J. Functions and pathophysiological roles of phospholipase D in the brain. Journal of Neurochemistry 2005, 94:1473-1487.
28. Kooijman E.E., Burger K.N. Biophysics and function of phosphatidic acid: a molecular perspective. Biochimica et Biophysica Acta 2009, 1791:881-888.
29. Lagus M., Gass N., Saharinen J., Saarela J., Porkka-Heiskanen T., Paunio T. Gene expression patterns in a rodent model for depression. European Journal of Neuroscience 2010, 31:1465-1473.
30. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
31. Lee K.S., Na Y.G., Dean-McKinney T., Klausner A.P., Tuttle J.B., Steers W.D. Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. Journal of Urology 2003, 170:2067-2071.
32. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
33. Liu Y., Zhang Y.W., Wang X., Zhang H., You X., Liao F.F., et al. Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1. The Journal of Biological Chemistry 2009, 284:12145-12152.
34. Marvan M.L., Chavez-Chavez L., Santana S. Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Archives of Medical Research 1996, 27:83-86.
35. Obergriesser T., Ende G., Braus D.F., Henn F.A. Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. Journal of Clinical Psychiatry 2003, 64:775-780.
36. Oliveira T.G., Chan R.B., Tian H., Laredo M., Shui G., Staniszewski A., et al. Phospholipase D2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. Journal of Neuroscience 2010, 30:16419-16428.
37. Oliveira T.G., Di Paolo G. Phospholipase D in brain function and Alzheimer's disease. Biochimica et Biophysica Acta 2010, 1801:799-805.
38. Sartorius A., Neumann-Haefelin C., Vollmayr B., Hoehn M., Henn F.A. Choline rise in the rat hippocampus induced by electroconvulsive shock treatment. Biological Psychiatry 2003, 53:620-623.
39. Savelyev S.A., Rantamaki T., Rytkonen K.M., Castren E., Porkka-Heiskanen T. Sleep homeostasis and depression: studies with the rat clomipramine model of depression. Neuroscience 2012, 212:149-158.
40. Toschi A., Lee E., Xu L., Garcia A., Gadir N., Foster D.A. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Molecular and Cellular Biology 2009, 29:1411-1420.
41. Vaishnavi S., Taylor W.D. Neuroimaging in late-life depression. International Review of Psychiatry 2006, 18:443-451.
42. Vogel G., Neill D., Hagler M., Kors D. A new animal model of endogenous depression: a summary of present findings. Neuroscience & Biobehavioral Reviews 1990, 14:85-91.
43. Wang X., Li Y.H., Li M.H., Lu J., Zhao J.G., Sun X.J., et al. Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. European Archives of Psychiatry and Clinical Neuroscience 2012, 262:33-38.
44. Winter J.N., Fox T.E., Kester M., Jefferson L.S., Kimball S.R. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. American Journal of Physiology 2010, 299:C335-C344.
45. Yildiz-Yesiloglu A., Ankerst D.P. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Research 2006, 147:1-25.
46. Zhang Y., Kanaho Y., Frohman M.A., Tsirka S.E. Phospholipase D1-promoted release of tissue plasminogen activator facilitates neurite outgrowth. Journal of Neuroscience 2005, 25:1797-1805.